Dr. Wiedau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UCLA Medical Center
710 Westwood Plaza, C119 RNRC
Los Angeles, CA 90095Phone+1 310-825-7266Fax+1 310-825-7266
Summary
- Dr. Martina Wiedau is a neurologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Ronald Reagan UCLA Medical Center, UCLA Medical Center-Santa Monica, and Providence Saint John's Health Center. She received her medical degree from Philipps University of Marburg Faculty of Medicine and has been in practice 26 years. She also speaks German. She specializes in neuromuscular medicine and is experienced in amyotrophic lateral sclerosis and general neurology. She is the director of the ALS Clinic and Research Center in the Department of Neurology at DGSOM at UCLA. In addition to her clinical work, she conducts clinical and basic ALS research. She is Medical Director and Vice Chair of Neurology at the UCLA Department of Neurology.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Neurology, 2000 - 2003
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 1997 - 2000
- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1996 - 1997
- Philipps University of Marburg Faculty of MedicineClass of 1991
Certifications & Licensure
- CA State Medical License 1998 - 2026
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Mexiletine for the Treatment of Muscle Cramps in ALS Start of enrollment: 2013 May 01
- Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS) Start of enrollment: 2019 Oct 21
Publications & Presentations
PubMed
- 8 citationsEdaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686].Benjamin Rix Brooks, Terry Heiman-Patterson, Martina Wiedau-Pazos, Shawn Liu, Jeffrey Zhang
Plos One. 2022-01-01 - 393 citationsGenome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosisWouter van Rheenen, Aleksey Shatunov, Annelot M. Dekker, Russell L. McLaughlin, Frank P. Diekstra
Nature Genetics. 2016-09-01 - 215 citationsCommon and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.Wouter van Rheenen, Rick A A van der Spek, Mark K Bakker, Joke J F A van Vugt, Paul J Hop
Nature Genetics. 2021-12-01
Grant Support
- MDAMDA2019–2023
- Project 2National Institute Of Neurological Disorders And Stroke2010–2012
- Gsk-3beta &Beta-Catenin In Pathophysiology Of FTDP-17National Institute Of Neurological Disorders And Stroke2004–2008
Professional Memberships
- Fellow
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: